Brimonidine

CAS Number: 59803-98-4

Molecular Formula: C11H10BrN5

Purity: Brimonidine 98% purity

About Brimonidine

Brimonidine (CAS 59803-97-1) serves as a cornerstone in the ophthalmic and dermatological sectors with a Pharma/API purity of 99%, specifically engineered for high-efficacy formulations targeting glaucoma, ocular hypertension, and facial erythema in rosacea. Brimonidine Tartrate has seen a robust increase in domestic d...

Synonyms

5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline D-tartrate
5-bromo-6-(imidazolidinylideneamino)quinoxaline
5-bromo-6-(imidazolin-2-ylamino)quinoxaline
AGN 190342
AGN-190342

View all

Brimonidine Specifications

CAS Number

59803-98-4

Molecular Formula

C11H10BrN5

Molecular Weight

292.14 g/mol

IUPAC Name

5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine

HSN No

30049099

CAS Number

59803-98-4

Molecular Formula

C11H10BrN5

Molecular Weight

292.14 g/mol

IUPAC Name

5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine

HSN No

30049099

Molecular Weight

292.14 g/mol

Purity

Brimonidine 98% purity

Antiglaucoma Agent

A selective alpha-2 adrenergic receptor agonist used in ophthalmic solutions to lower intraocular pressure in patients with open-angle glaucoma or ocular hypertension by reducing aqueous humor production and increasing uveoscleral outflow

Pharmaceutical Intermediate

A quinoxaline derivative utilized as an active pharmaceutical ingredient in the formulation of eye drops to prevent increased intraocular pressure after surgical procedures such as argon laser trabeculoplasty

Dermatological Agent

A topical vasoconstrictive agent used for the symptomatic treatment of persistent facial erythema associated with rosacea in adults

Research Tool

A high-selectivity adrenergic agonist employed in pharmacological studies to investigate alpha-2 adrenoceptor binding and its neuroprotective effects on retinal ganglion cells.